COMMUNIQUÉS West-GlobeNewswire
 
      -   
  Women, Men Say More Solutions Needed In The Workplace In Light Of #MeToo, Survey Reveals02/05/2018
-   
  TOMI™ Environmental Solutions, Inc. Announces New Sales Leadership02/05/2018
-   
  Yield Endurance Strategic Partner Closes on Initial Loan of 110 Bitcoins02/05/2018
-   
  SELLAS Life Sciences Completes Second Tranche of $10,700,000 Private Placement02/05/2018
-   
  Asterias Biotherapeutics to Present Safety and Efficacy Data from AST-OPC1 SCiStar Study at the American Spinal Injury Association (ASIA) 2018 Annual Meeting02/05/2018
-   
  ChemoCentryx to Hold First Quarter 2018 Financial Results Conference Call on Wednesday, May 9, 201802/05/2018
-   
  Rockwell Medical Announces Triferic® Presentations at the 2018 International Congress on Peritoneal Dialysis02/05/2018
-   
  VistaGen Therapeutics Receives Notice of Allowance for Japanese Patent regarding Methods of Production for AV-10102/05/2018
-   
  Hemispherx Provides an Update to Stockholders Highlighting Cancer Focus and $10 Million Booked Since Start of Year Will Support Increased Production of Ampligen for Immuno-Oncology Clinical Trials02/05/2018
-   
  Verona Pharma to Announce Operational Update and Financial Results for First Quarter Ended March 31, 201802/05/2018
-   
  Trading by management and close relations of management02/05/2018
-   
  Catalyst Pharmaceuticals to Hold First Quarter Financial Results and Corporate Update Conference Call and Webcast on Thursday, May 10th, 201802/05/2018
-   
  Iovance Biotherapeutics to Present at Two Upcoming Investor Conferences in May02/05/2018
-   
  Endocyte Announces First Quarter 2018 Earnings Call02/05/2018
-   
  Chimerix to Present at the Deutsche Bank 43rd Annual Health Care Conference02/05/2018
-   
  Selecta Biosciences Announces Date of First Quarter 2018 Financial Results Conference Call02/05/2018
-   
  AMAG Pharmaceuticals Appoints J. Alan Butcher as Executive Vice President and Chief Business Officer02/05/2018
-   
  Jounce Therapeutics to Announce First Quarter 2018 Financial Results and Host Conference Call on Wednesday, May 9, 201802/05/2018
-   
  Cellectar Receives Rare Pediatric Disease Designation for CLR 131 to Treat Neuroblastoma02/05/2018
Pages